Response to letter regarding article 'Fingolimod effects on left ventricular function in multiple sclerosis'

Mult Scler. 2016 Apr;22(5):708-9. doi: 10.1177/1352458515600251. Epub 2015 Sep 10.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Fingolimod Hydrochloride*
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Multiple Sclerosis / drug therapy*
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy
  • Sphingosine
  • Ventricular Function, Left

Substances

  • Immunosuppressive Agents
  • Fingolimod Hydrochloride
  • Sphingosine